Drug Research
Cellectricon introduces Cellaxess discovery platform
Cellectricon has launched a new Cellaxess elektra discovery platform for automated electric field manipulation of adherent cells. Developed in collaboration...
Drug Research
Aegis wins US patent for octreotide formulations
Aegis Therapeutics has received US patent covering pharmaceutical composition of octreotide. The octreotide formulations incorporate Aegis' Intravail/ProTek excipients suitable for...
Drug Research
Cellectis introduces human iPS derived hepatocyte product
Cellectis stem cells, a business unit of Cellectis Group, has introduced hiPS-HEP, a human iPS derived hepatocyte product. The hiPS-HEP,...
Drug Research
Antares, Watson Pharmaceuticals launch Gelnique 3% in US
Antares Pharma and Watson Pharmaceuticals have introduced Gelnique 3% (oxybutynin) gel 3%, for the treatment of overactive bladder. The product...
Drug Research
Meridian, Teva settle epinephrine auto-injector pending patent litigation
Meridian Medical Technologies, a Pfizer subsidiary, and Teva have entered into a settlement agreement to resolve generic epinephrine auto-injector pending patent litigation. ...
Drug Research
Affymax, Takeda launch OMONTYS injection in US
Affymax and Takeda Pharmaceutical Company have announced the availability of OMONTYS injection to treat anemia due to chronic kidney disease (CKD) in adult patients...
Drug Research
Watson introduces generic version of Fortamet
Watson Pharmaceuticals has introduced an authorized generic version of Fortamet as a part of an agreement with Shionogi. The company...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.